Pola-R-CHP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of randomized trials and real-world evidence
This meta-analysis was triaged for T1 - Hematologic Malignancies based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with stronger evidence maturity.
This meta-analysis was triaged for T1 - Hematologic Malignancies based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with stronger evidence maturity.
What the study was
- Study design
- Meta-analysis
- Sample size
- 3472
- Maturity
- Potentially Practice-Changing
- Journal
- Blood cancer journal
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.